WHO recommends Merck Covid-19 pill for non-severe, at-risk patients

WHO recommends Merck Covid-19 pill for non-severe, at-risk patients - Hello loyal readers FeedGoogle, In the article you are reading this time with the title WHO recommends Merck Covid-19 pill for non-severe, at-risk patients, We have prepared this article well for you to read and take information in it. hopefully the contents of the post Article World, what we write you can understand. Alright, happy reading.

Molnupiravir is developed by US pharmaceutical Merck and is taken as soon as possible after Covid-19 symptoms develop and then for the following five days. —Merck & Co Inc/Handout via Reuters Follow us on Instagram and subscribe to our Telegram channel for the latest updates. PARIS, March 3 ― The World Health Organisation (WHO) yesterday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.The pill, called molnupiravir and developed by US pharmaceutical Merck, is taken as soon as possible after Covid-19 symptoms develop and then for the following five days.A WHO group of experts said in the British Medical Journal that people with weak immune systems or chronic disease were also recommended to take the pill if they had non-severe Covid.However “young and healthy patients,…